| Health / Medical Topics |
Pargyline
A monoamine oxidase (MAO) inhibitor with antidepressant activity. Pargyline selectively inhibits MAO type B, an enzyme catalyzing the oxidative deamination and inactivation of certain catecholamines, such as norepinephrine and dopamine, within the presynaptic nerve terminals. By inhibiting the metabolism of these biogenic amines in the brain, pargyline increases their concentration and binding to postsynaptic receptors. Increased receptor stimulation may cause downregulation of central receptors which may attribute to pargyline's antidepressant effect. (NCI Thesaurus)
YOU MAY ALSO LIKE
An abnormal touch sensation, such as burning or prickling, that occurs without an outside stimulus.
A slight or incomplete paralysis.
If you're a parent, you get plenty of suggestions on how to raise your child. From experts to other parents, people are…
A container designed for use with parenteral drug products.
Administration of a substance by some means other than through the gastrointestinal tract: usually through injection, infusion, or implantation. Predominantly, the drug…
A form of nutrition that is delivered into a vein. Parenteral nutrition does not use the digestive system. It may be given…
